Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial Based on the Theory of Planned Behavior

Table 6

Ultrasound changes of NAFLD grade and liver enzymes at baseline and end of trial in patients.

		Control ()			Intervention ()
		Baseline	End-of-trial		Baseline	End-of-trial		Baseline	End-of-trial
Liver enzymes	ALT			0.672			<0.001	0.855	0.005
	AST			0.194			<0.001	0.627	<0.001
Fatty liver (%)	No fatty liver	0	0	^c0.999	0	8 (19)	^c0.002	^d0.974	^d0.009
	Grade I	32 (71.1)	31 (68)		30 (41.4)	24 (57)
	Grade II	13 (28.9)	14 (31)		12 (28.6)	10 (23)

Data are . ALT: alanine aminotransferase; AST: aspartate aminotransferase. ^aObtained from Wilcoxon test. ^bObtained from Mann-Whitney test. ^cObtained from sign test. ^dObtained from Chi-square test.